KSC Equity Snapshot
003220 Weekly Equity Report
Daewon Pharmaceutical Co., Ltd.
What the company does
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately …
What the weekly tape is saying
003220 closed the latest completed week at 9,240 KRW. The 4-week return is -6.1% and the 12-week return is -11.3%. Trend Signal is inactive, Market Dynamics is -0.36. Setup signature: Risk-first tape with a 28/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 11,050 KRW
- Vs Trend Line
- -16.4%
- Fair Value
- 13,467 KRW
- Vs Fair Value
- -31.4%
- 52W High
- 13,670 KRW
- 52W Low
- 8,070 KRW
- Drawdown
- -32.4%
- Range Position
- 20.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- KR Healthcare
- Sector Rank
- 63 of 63
- Sector Percentile
- 0.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 13 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 8 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.36
- 4W MD Change
- -8.0%
- Relative Strength
- -59.57
- 4W RS Change
- -3.4%
- Expectation
- Undecided
- Probability
- 47.30%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.9M
- 13W Average
- 528.1K
- 52W Average
- 249.6K
- Vs 13W
- 9.2x
- Vs 52W
- 19.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.1%
- 52W Volatility
- 5.4%
- Upside Weeks
- 21
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 2.7% / -2.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 178.8B
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 9,240 KRW | -17.8% | 11,050 KRW | 13,467 KRW | -0.36 | -59.57 | 4.9M | Off |
| 5 Jun 2026 | 11,240 KRW | 28.8% | 11,181 KRW | 13,492 KRW | -0.47 | -52.18 | 307.6K | Off |
| 29 May 2026 | 8,730 KRW | -8.3% | 11,230 KRW | 13,506 KRW | -0.85 | -65.04 | 154.4K | Off |
| 22 May 2026 | 9,520 KRW | -3.3% | 11,363 KRW | 13,538 KRW | -0.56 | -59.88 | 196.8K | Off |
| 15 May 2026 | 9,840 KRW | -3.3% | 11,472 KRW | 13,563 KRW | -0.33 | -57.63 | 244.0K | Off |
| 8 May 2026 | 10,180 KRW | -5.0% | 11,572 KRW | 13,587 KRW | -0.17 | -57.17 | 120.5K | Off |
| 1 May 2026 | 10,720 KRW | -1.9% | 11,658 KRW | 13,610 KRW | -0.31 | -49.92 | 100.3K | Off |
| 24 Apr 2026 | 10,930 KRW | -1.2% | 11,729 KRW | 13,633 KRW | -0.58 | -49.08 | 128.6K | Off |
| 17 Apr 2026 | 11,060 KRW | 7.4% | 11,789 KRW | 13,652 KRW | -0.84 | -47.22 | 227.0K | Off |
| 10 Apr 2026 | 10,300 KRW | 0.4% | 11,852 KRW | 13,669 KRW | -1.18 | -49.06 | 128.6K | Off |
| 3 Apr 2026 | 10,260 KRW | -2.5% | 11,936 KRW | 13,695 KRW | -1.16 | -45.79 | 96.8K | Off |
| 27 Mar 2026 | 10,520 KRW | 1.0% | 12,017 KRW | 13,718 KRW | -1.16 | -46.05 | 137.6K | Off |
| 20 Mar 2026 | 10,420 KRW | -1.0% | 12,094 KRW | 13,738 KRW | -0.96 | -50.61 | 168.2K | Off |
| 13 Mar 2026 | 10,530 KRW | -1.6% | 12,172 KRW | 13,758 KRW | -0.81 | -48.34 | 196.4K | Off |